The global spatial genomics and transcriptomics market is expected to grow from USD 355 million in 2022 to USD 800 million by 2027, exhibiting a robust CAGR of 17.6%. This growth is primarily driven by the increasing adoption of spatial genomics and transcriptomics techniques in drug discovery and development. Additionally, the rise in research and development investments and public-private funding, along with the introduction of technologically advanced instruments, are propelling market expansion.
read more..